Cited by 96Gastrointestinal motility and disordersDigestive system and related healthGenomics and Rare Diseases

Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients

Open access
Garcia-Etxebarria, Koldo, Zheng, Tenghao, Bonfiglio, Ferdinando, Bujanda, Luis, Dlugosz, Aldona, Lindberg, Greger, Schmidt, Peter T., Karling, Pontus +22 more·2018·Clinical Gastroenterology and Hepatology

Abstract

Patients with irritable bowel syndrome (IBS) often associate their symptoms to certain foods. In congenital sucrase-isomaltase deficiency (CSID), recessive mutations in the SI gene (coding for the disaccharidase digesting sucrose and 60% of dietary starch)1 cause clinical features of IBS through colonic accumulation of undigested carbohydrates, triggering bowel symptoms.2 Hence, in a previous study,3 we hypothesized that CSID variants reducing SI enzymatic activity may contribute to development of IBS symptoms. We detected association with increased risk of IBS for 4 rare loss-of-function variants typically found in (homozygous) CSID patients, because carriers (heterozygous) of these rare variants were more common in patients than in controls.1,4 Through a 2-step computational and experimental strategy, the present study aimed to determine whether other (dys-)functional SI variants are associated with risk of IBS in addition to known CSID mutations. We first aimed to identify all SI rare pathogenic variants (SI-RPVs) on the basis of integrated Mendelian Clinically Applicable Pathogenicity (M-CAP) and Combined Annotation Dependent Depletion (CADD) predictive (clinically relevant) scores; next, we inspected genotype data currently available for 2207 IBS patients from a large ongoing project to compare SI-RPV case frequencies with ethnically matched population frequencies from the Exome Aggregation Consortium (ExAC).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2018.01.047

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A systematic review demonstrated few consistent findings in IBS and certainly no microbiome signature differentiating IBS subgroups.

    “A systematic review demonstrated few consistent findings in IBS (possibly because age, sex, race, diet, and antibiotic intake were not controlled for in included studies), and certainly no microbiome signature differentiating IBS subgroups. 42”

    From Irritable bowel syndrome (2020) · cites this paper as [42]

    The Methods and Results describe an analysis of sucrase-isomaltase genetic variants in IBS patients, not a systematic review of microbiome studies. Searches for a microbiome signature, IBS subgroups, and the proposed study confounders found no passage addressing the attributed claim. (LLM, conf=0.77)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Garcia-Etxebarria, K., Zheng, T., Bonfiglio, F., Bujanda, L., Dlugosz, A., Lindberg, G., Schmidt, P. T., Karling, P., Ohlsson, B., Simren, M., Walter, S., Nardone, G., Cuomo, R., Usai-Satta, P., Galeazzi, F., Neri, M., Portincasa, P., Bellini, M., Barbara, G., Jonkers, D., Eswaran, S., Chey, W. D., Kashyap, P., Chang, L., Mayer, E. A., Wouters, M. M., Boeckxstaens, G., Camilleri, M., Franke, A., & D’Amato, M.
Affiliations
  • Karolinska Institutet (SE)
  • Karolinska University Hospital (SE)
  • University of the Basque Country (ES)
  • Umeå University (SE)
  • Lund University (SE)
  • Linköping University (SE)
  • Federico II University Hospital (IT)
  • University of Padua (IT)
  • University of Chieti-Pescara (IT)
  • University of Bari Aldo Moro (IT)
  • University of Pisa (IT)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • Maastricht University Medical Centre (NL)
  • University of Michigan (US)
  • Mayo Clinic (US)
  • University of California, Los Angeles (US)
  • KU Leuven (BE)
  • Ikerbasque (ES)
Corresponding author
D’Amato, Mauro
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2018-10
Volume
16
Issue
10
Pages
1673-1676
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2785706387
Cited by
96
References
8
Citations by year
2026: 9 · 2025: 12 · 2024: 14 · 2023: 9 · 2022: 12 · 2021: 15 · 2020: 14 · 2019: 9 · 2018: 2
FWCI
9.52
Type
journal article
Language
en
Open access
Locations
  • Clinical Gastroenterology and Hepatology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by-nc-nd)
  • Lirias (submittedVersion, cc-by-nc-nd)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by-nc-nd)
  • Research Publications (Maastricht University) (submittedVersion, cc-by-nc-nd)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
  • Lund University Publications (Lund University) (submittedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Swedish Research Council
  • Health Department of the Basque Government (2015111133)
  • Spanish Ministry of Economy and Competitiveness (FIS PI17/00308)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Digestive system and related health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
irritable bowel syndrome, sucrase-isomaltase deficiency, rare pathogenic variants, loss-of-function mutations, genetic risk, heterozygous carriers, CADD score, ExAC
MeSH terms
Gene Frequency, Genotype, Humans, Sucrase-Isomaltase Complex, Prevalence, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review